Brought to you by 
Anthera Pharmaceuticals completes $36mm Series A round
19 Sep 2006
Executive Summary
Anthera Pharmaceuticals (therapeutics for inflammatory diseases) has raised $36mm with its Series A venture round. VantagePoint Venture Partners and Sofinnova Ventures led the financing and were joined by fellow new investors Pappas Ventures and Mitsubishi International, as well as returning backers Sears Capital Management and SIM Equity.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Anthera Pharmaceuticals completes $36mm Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice